{"id":1180,"date":"2020-05-05T16:10:26","date_gmt":"2020-05-05T15:10:26","guid":{"rendered":"https:\/\/thedailyleaks.com\/?p=1180"},"modified":"2020-05-05T17:56:16","modified_gmt":"2020-05-05T16:56:16","slug":"pfizer-biontech-begin-experimental-testing-for-coronavirus-vaccine-on-humans-in-us","status":"publish","type":"post","link":"https:\/\/thedailyleaks.com\/pfizer-biontech-begin-experimental-testing-for-coronavirus-vaccine-on-humans-in-us\/","title":{"rendered":"Pfizer, BioNTech begin experimental testing for coronavirus vaccine on humans in US"},"content":{"rendered":"
Pfizer, BioNTech begin experimental testing for coronavirus vaccine on humans in US<\/p>\n
Pfizer<\/a>\u00a0said Tuesday it has begun testing an experimental vaccine to combat\u00a0the coronavirus<\/a>\u00a0in the United States.<\/p>\n The U.S.-based pharmaceutical giant, which is working alongside German drugmaker BioNTech, said the first human participants in the United States have been dosed with the potential vaccine, BNT162. They began human trials of the experimental vaccine late last month in Germany, CNBC<\/a> said.<\/p>\n “With our unique and robust clinical study program underway, starting in Europe and now the U.S., we look forward to advancing quickly and collaboratively with our partners at BioNTech and regulatory authorities to bring a safe and efficacious vaccine to the patients who need it most,” Pfizer Chairman and CEO Albert Bourla said in a statement.<\/p>\n “The short, less than four-month time frame in which we’ve been able to move from preclinical studies to human testing, is extraordinary,” he added.<\/p>\n ALSO READ:\u00a0<\/strong>Facebook\u2019s Oculus developing smaller, lighter Quest Virtual Reality headset<\/a><\/strong><\/p>\n The experimental vaccine contains genetic material called messenger RNA, or mRNA.\u00a0The mRNA is a genetic code that tells cells what to build \u2014 in this case, an antigen that may induce an immune response for the virus.<\/p>\n The trial will test the experimental vaccine on adults ages 18 to 55 in the first stage before moving on to older groups, the company said, adding it hopes to test up to 360 people.<\/p>\n There are no FDA-approved therapies to treat Covid-19, and drugmakers are racing to produce a vaccine, which U.S. health officials say is expected to take at least 12 to 18 months.<\/p>\n The effort by Pfizer and\u00a0BioNTech is one of several working on a potential vaccine to prevent Covid-19, which has sickened more than 3.5 million people worldwide and has killed at least 247,752 as of Monday night, according to data compiled by Johns Hopkins University. There were more than 100 vaccines in development globally as of April 30,\u00a0according to the World Health Organization<\/a>, with at least eight vaccine candidates already in human trials.<\/p>\n Hopes to get a vaccine to market are high, but scientists are setting expectations low for how quickly it can happen. Developing, testing and reviewing any potential vaccine is a long, complex and expensive endeavor that could take years, global health experts say.<\/p>\n Biotech firm\u00a0Moderna<\/a>, in partnership with the National Institutes of Health,\u00a0began the first human trial testing for a potential vaccine<\/a>\u00a0in March.<\/p>\n Johnson & Johnson<\/a>\u00a0said it is aiming to produce\u00a0600 million to 900 million doses<\/a>\u00a0of its potential coronavirus vaccine by the end of the first quarter of 2021 if human trials scheduled to begin in September go as planned.<\/p>\n Pfizer hopes to produce “millions” of vaccines by the end of this year, the company’s chief scientific officer, Dr. Mikael Dolsten, told\u00a0CNBC last<\/a>\u00a0month. The company said Tuesday it expects to increase to “hundreds of millions” of doses next year.<\/p>\n Sites currently dosing participants include\u00a0NYU Grossman School of Medicine and the University of Maryland School of Medicine, Pfizer said. The University of Rochester Medical Center, Rochester Regional Health and Cincinnati Children’s Hospital Medical Center will “begin enrollment shortly,” the company said.<\/p>\n Upon regulatory approval, Pfizer and BioNTech will work jointly to commercialize the vaccine worldwide.<\/p>\n","protected":false},"excerpt":{"rendered":" Pfizer, BioNTech begin experimental testing for coronavirus vaccine on humans in US Pfizer\u00a0said Tuesday it has begun testing an experimental vaccine to combat\u00a0the coronavirus\u00a0in the United States. The U.S.-based pharmaceutical giant, which is working alongside […]<\/a><\/p>\n<\/div>","protected":false},"author":2,"featured_media":1181,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[18,2],"tags":[],"coauthors":[25],"class_list":{"0":"post-1180","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-health","8":"category-top-news"},"yoast_head":"\n